drugset / Trial / NCT02735499
Instillation of Botox in the Bladder in Women With Overactive Bladder (OAB)
Phase 2
Completed
14 enrolled
The Hospital of Vestfold
South-Eastern Norway Regional Health Authority · collab
NaSingle-groupOpen-labelTreatment
Summary
Instillation treatment with onabotulinumtoxin A (BOTOX®) in the urinary bladder
Timeline
- Start
- 2016-03
- Primary completion
- 2016-10
- Completion
- 2016-10
Publications
- Background Duthie JB, Vincent M, Herbison GP, Wilson DI, Wilson D. Botulinum toxin injections for adults with overactive bladder syndrome. Cochrane Database Syst Rev. 2011 Dec 7;2011(12):CD005493. doi: 10.1002/14651858.CD005493.pub3.
- Background Kajbafzadeh AM, Ahmadi H, Montaser-Kouhsari L, Sharifi-Rad L, Nejat F, Bazargan-Hejazi S. Intravesical electromotive botulinum toxin type A administration--part II: Clinical application. Urology. 2011 Feb;77(2):439-45. doi: 10.1016/j.urology.2010.06.003. Epub 2010 Aug 30.
- Results Schiøtz HA, Mai HT, Zabielska R. Intravesical Electromotive Botulinum Toxin in Women with Overactive Bladder - a pilot study. AJGO 2017; 2: 4-10. https://www.arcjournals.org/pdfs/ajgo/v2-i2/2.pdf
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 200 iu | Other |